“Phytocompound of pure thymol inhibit COVID-19 by binding to ACE2 receptor: In silico approach” (2022) Journal of Pharmaceutical Negative Results, 13(1), pp. 14–19. Available at: https://www.pnrjournal.com/index.php/home/article/view/185 (Accessed: 24 June 2026).